Rangel-Gamboa Lucia, Reyes-Castro Magdalena, Dominguez-Cherit Judith, Vega-Memije Elisa
Division of Investigation, General Hospital "Dr. Manuel Gea González", Calz. Tlalpan 4800, Seccion VX, C.P 14000, México.
Department of Pathology, General Hospital "Dr. Manuel Gea González", Calz. Tlalpan 4800, Seccion VX, C.P 14000, México.
Int J Trichology. 2013 Jul;5(3):115-7. doi: 10.4103/0974-7753.125599.
A proliferating trichilemmal cyst (PTC) is an uncommon, rapidly-reproducing cutaneous epithelial cyst, differentiating from the isthmic portion of the outer hair root sheath. It is usually described as a benign tumor, but malignant transformation has been reported and is then denominated as a malignant proliferating trichilemmal tumor. Ki67 immunostaining has been used as a methodology for the evaluation of tumor grade in other tumors, due to its distinctive reaction patterns which exclusively involve proliferating cells.
(1) To report the incidence of cases of PTCs in a General Hospital during a 12 years period. (2) To determine the expression of ki67 using immunohistochemical staining. (3) To correlate ki67 reaction patterns with clinical prognosis.
The dermatology department's files during a period of 12 years were reviewed; cases with a diagnosis of PTC were selected, and ki67 immunostaining was done when enough biological material was available.
A total of 15 cases with a diagnosis of PTC were identified. In 12 cases, ki67 immunostaining was carried out. In 9 of the 12 cases, ki67 was observed in the basal cells of the cystic epithelium, one case was moderately positive in palisading epithelial cells; in the other two cases ki67 immunostaining was negative. Clinical follow-up was done and revealed that no patient had local recurrence in 5 years after surgical removal of PTC. We therefore consider this immunostaining technique is probably correlated with low recurrence potential.
增殖性外毛根鞘囊肿(PTC)是一种罕见的、快速增殖的皮肤上皮囊肿,起源于外毛根鞘的峡部。它通常被描述为一种良性肿瘤,但已有恶性转化的报道,此时被命名为恶性增殖性外毛根鞘肿瘤。由于Ki67独特的反应模式仅涉及增殖细胞,因此在其他肿瘤中,Ki67免疫染色已被用作评估肿瘤分级的方法。
(1)报告一家综合医院12年间PTC病例的发生率。(2)使用免疫组织化学染色确定Ki67的表达。(3)将Ki67反应模式与临床预后相关联。
回顾皮肤科12年间的病历;选择诊断为PTC的病例,当有足够的生物材料时进行Ki67免疫染色。
共确定15例诊断为PTC的病例。其中12例进行了Ki67免疫染色。在12例中的9例中,在囊性上皮的基底细胞中观察到Ki67,1例在栅栏状上皮细胞中呈中度阳性;另外2例Ki67免疫染色为阴性。进行了临床随访,结果显示PTC手术切除后5年内无患者局部复发。因此,我们认为这种免疫染色技术可能与低复发潜能相关。